Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buhmann

Showing results (151-160 of 520) with videos related to

Pageof 52
Sort By:
Journal of Neurology|August 9, 2024
German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventionsElke Kalbe, Ann-Kristin Folkerts, Karsten Witt, et al.
Zeitschrift Fur Kardiologie|June 21, 2016
[Multiple off pump coronary artery bypass grafting - risks and benefits]J Ennker, S Bauer, U Buhmann, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 18, 2024
The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial - CORRIGENDUMCaecilie Böck Buhmann, Merete Nordentoft, Morten Ekstroem, et al.
Scientific Reports|July 15, 2017
Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetryBirthe Stemplewitz, Robert Kromer, Eik Vettorazzi, et al.
Frontiers in Neurology|December 19, 2022
Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic reviewSusan Seddiq Zai, Christoph Heesen, Carsten Buhmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantroneC Heesen, M Bruegmann, J Gbdamosi, et al.
Fortschritte Der Neurologie-Psychiatrie|April 18, 2020
[The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care]Odette Fründt, Ermir Veliqi, Beate Schönwald, et al.
European Neurology|March 21, 2003
Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10Joystone Gbadamosi, Carsten Buhmann, Wiebke Tessmer, et al.
Acta Ophthalmologica|August 13, 2015
Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomographyDiana Bittersohl, Birthe Stemplewitz, Matthias Keserü, et al.
The Journal of Infectious Diseases|February 1, 2022
Antibody Course and Memory B-Cell Response in the First Year After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJudith Kannenberg, Henning Trawinski, Reinhard Henschler, et al.
Pageof 52

Showing results (151-160 of 520) with videos related to

Sort By:
Pageof 52
Journal of Neurology|August 9, 2024
German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventionsElke Kalbe, Ann-Kristin Folkerts, Karsten Witt, et al.
Zeitschrift Fur Kardiologie|June 21, 2016
[Multiple off pump coronary artery bypass grafting - risks and benefits]J Ennker, S Bauer, U Buhmann, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 18, 2024
The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial - CORRIGENDUMCaecilie Böck Buhmann, Merete Nordentoft, Morten Ekstroem, et al.
Scientific Reports|July 15, 2017
Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetryBirthe Stemplewitz, Robert Kromer, Eik Vettorazzi, et al.
Frontiers in Neurology|December 19, 2022
Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic reviewSusan Seddiq Zai, Christoph Heesen, Carsten Buhmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantroneC Heesen, M Bruegmann, J Gbdamosi, et al.
Fortschritte Der Neurologie-Psychiatrie|April 18, 2020
[The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care]Odette Fründt, Ermir Veliqi, Beate Schönwald, et al.
European Neurology|March 21, 2003
Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10Joystone Gbadamosi, Carsten Buhmann, Wiebke Tessmer, et al.
Acta Ophthalmologica|August 13, 2015
Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomographyDiana Bittersohl, Birthe Stemplewitz, Matthias Keserü, et al.
The Journal of Infectious Diseases|February 1, 2022
Antibody Course and Memory B-Cell Response in the First Year After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJudith Kannenberg, Henning Trawinski, Reinhard Henschler, et al.
Pageof 52